Amir M Emtiazjoo, MD, MSc - Research

Research at a glance

Top areas of exploration

Lung Transplantation , 21 publications
Disease Models, Animal , 6 publications
Extracorporeal Membrane Oxygenation , 5 publications
Respiratory Insufficiency , 4 publications

Research activity

42 publications

419 citations

Why is this important?

Active clinical trials

BOSTON 3

The objective of the trial is to assess the long-term safety and efficacy of L-CsA plus Standard of Care (SoC) in the treatment of BOS in single (SLT) and double lung transplant (DLT) recipients.

Investigator: Amir M Emtiazjoo
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

My publications

42 publications

2024

The common TMEM173 HAQ, AQ alleles rescue CD4 T cellpenia, restore T-regs, and prevent SAVI (N153S) inflammatory disease in mice.

bioRxiv : the preprint server for biology

鈥�

2024

Venovenous ECMO for Acute Chronic Heart Failure after Bilateral Lung Transplantation.

Annals of cardiac anaesthesia

鈥�

2023

Management of nontuberculous mycobacteria in lung transplant cases: an international Delphi study.

ERJ open research

鈥�

2023

Resolution of post-lung transplant ischemia-reperfusion injury is modulated via Resolvin D1-FPR2 and Maresin 1-LGR6 signaling.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

鈥�

2022

Hyperammonemia After Lung Transplantation: Systematic Review and a Mini Case Series.

Transplant international : official journal of the European Society for Organ Transplantation

鈥�

网红黑料